23 October 2026
Hormone therapy with GLP-1s tied to more weight loss
A 2,379-woman cohort on semaglutide or tirzepatide showed higher loss with concurrent hormone therapy from 9 months on.
The full briefing is in the app.
23 October 2026
A 2,379-woman cohort on semaglutide or tirzepatide showed higher loss with concurrent hormone therapy from 9 months on.
The full briefing is in the app.